| Sample ID | A unique identifier assigned to a biological specimen used in the imaging experiment | liver_01 | required | required |
| Slide ID | A unique identifier for the glass slide or cartridge on which the tissue section was mounted and processed | BSMC_01 | required | required |
| Position on slide | Describe where the capture area is located on the slide. This is required if the slide contains multiple capture areas, for example for visium | Area A1; number 1 | optional | optional |
| Sample preservation method | The method used to preserve the tissue prior to processing (e.g., fresh frozen, FFPE) | fresh frozen | required | required |
| Organism name | The scientific name of the source organism (e.g., Homo sapiens, Mus musculus) | Homo sapiens (NCBITaxon:9606) | required | required |
| Time from collection to preservation | Elapsed time between tissue excision/collection and preservation, reported in hours | 1h | optional | optional |
| Section thickness | The thickness of the tissue section mounted on the slide, reported in micrometers (µm) | 5 µm | required | required |
| Protocol for fixing section | Detailed description or reference to the fixation protocol used (fixative type, duration, temperature, buffer) | Tissues were fixed in 10% neutral-buffered formalin (VWR) for 24 hours at 4 ºC before being transferred to 70% ethanol at 4 ºC. Samples were then embedded in paraffin blocks and sectioned | required | required |
| Organ | Tissue origin | kidney (UBERON:0002113) | required | required |
| Anatomical region | The anatomical location from which the tissue was obtained, preferably using standardized anatomical ontologies. | Inner medulla of kidney (UBERON:0001294) | required | required |
| Donor health status at sampling | Relevant disease information from the donor at the time of sample collection | healthy, adenocarcinoma | required | required |
| Sample disease status | Disease information for the specific sample irrespective of the donor health status | benign, adenocarcinoma | optional | optional |
| Additional sample description | Any additional information about the sample that would be useful for reanalysis. For example can include: longitudinal sample collection, graft information, disease severity or grade | This sample is the second sample from a timeseries of samples collected from the donor, (2/5) samples collected 3 months after sample 1. | optional | optional |
| Sex | Biological sex of the donor organism | male | required | required |
| Age | Age of the donor at time of sampling | 35 | conditionally required (age or developmental stage) | conditionally required (age or developmental stage) |
| Developmental stage | Developmental stage for animal models | blastula | conditionally required (age or developmental stage) | conditionally required (age or developmental stage) |
| Sample collection protocol | Detailed description of the sample collection protocol, including the clinical procedure used to obtain the tissue (core biopsy, surgical resection, needle biopsy, collecting specimen from organ postmortem, etc) | Adult tissue was obtained from surgical remnants of heathy skin taken for reconstructive surgery. All samples were collected in Medium 154 (Gibco) with 1× Antibiotic-Antimycotic (Gibco) at 4 °C until dissociation. | optional | optional |